Semaglutide is contraindicated in patients with: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Common Adverse Effects According to clinical trial data, gastrointestinal effects are most frequently reported: nausea, vomiting, diarrhea, constipation, and abdominal discomfort
DPP-4 is known to cleave a broad range of substrates, rendering them inactive including growth factors, neuropeptides, and vasoactive peptides
An honest answer about the tiny needle, plus a simple guide to injecting at home
At Lily Aesthetics, we can customize a treatment plan that combines your Medical Weight Loss and Wellness program with complementary aesthetic services based on your individual goals
Good care is not about chasing the newest name